What is the recommended starting dose of Lantus (insulin glargine) for a patient with type 1 or type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lantus (Insulin Glargine) Dosing

Starting Dose for Type 2 Diabetes

For insulin-naive patients with type 2 diabetes, start Lantus at 10 units once daily OR 0.1-0.2 units/kg body weight, administered at the same time each day. 1, 2, 3

  • The FDA-approved starting dose is 0.2 units/kg or up to 10 units once daily 3
  • Continue metformin (unless contraindicated) and possibly one additional non-insulin agent when initiating basal insulin 1
  • For patients with severe hyperglycemia (HbA1c ≥9%, blood glucose ≥300-350 mg/dL), consider higher starting doses of 0.3-0.5 units/kg/day as total daily insulin using a basal-bolus regimen from the outset 1

Starting Dose for Type 1 Diabetes

For type 1 diabetes, the recommended starting dose is approximately one-third of total daily insulin requirements (typically 0.4-1.0 units/kg/day total insulin), with Lantus providing the basal component. 2, 3

  • For metabolically stable patients, start with 0.5 units/kg/day total insulin, giving approximately 50% as Lantus (basal) and 50% as rapid-acting insulin (prandial) divided among meals 1, 2
  • Higher doses are required immediately following diabetic ketoacidosis presentation 2
  • Lantus must be used concomitantly with short-acting insulin in type 1 diabetes 3

Dose Titration Algorithm

Increase Lantus by 2-4 units every 3 days until fasting blood glucose reaches 80-130 mg/dL (4.4-7.2 mmol/L). 1, 4

  • If fasting glucose is 140-179 mg/dL: increase by 2 units every 3 days 1
  • If fasting glucose is ≥180 mg/dL: increase by 4 units every 3 days 1, 4
  • If hypoglycemia occurs without clear cause: reduce dose by 10-20% immediately 1, 4
  • If more than 2 fasting values per week are <80 mg/dL: decrease dose by 2 units 1, 4

Critical Dosing Threshold: When to Stop Escalating Basal Insulin

When Lantus exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day, add prandial insulin rather than continuing to escalate basal insulin alone. 1, 4

  • Clinical signals of "overbasalization" include: basal dose >0.5 units/kg/day, bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia episodes, and high glucose variability 1
  • Start prandial insulin with 4 units of rapid-acting insulin before the largest meal, or use 10% of current basal dose 1
  • Continuing to escalate basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia leads to suboptimal control and increased hypoglycemia risk 1, 4

Administration Guidelines

Administer Lantus subcutaneously once daily at the same time each day into the abdominal area, thigh, or deltoid. 3

  • Rotate injection sites within the same region to reduce risk of lipodystrophy 3
  • Do not administer intravenously or via insulin pump 3
  • Do not dilute or mix Lantus with any other insulin or solution 3
  • Lantus can be given at any time of day, but consistency in timing is essential 1

Monitoring Requirements

Daily fasting blood glucose monitoring is essential during the titration phase. 1, 4

  • Reassess every 3 days during active titration 1, 4
  • Reassess every 3-6 months once stable 1, 4
  • Increase frequency of blood glucose monitoring during any changes to insulin regimen 3

Common Pitfalls to Avoid

  • Never delay insulin initiation in patients not achieving glycemic goals with oral medications 1
  • Never discontinue metformin when starting insulin unless contraindicated 1
  • Never continue escalating basal insulin beyond 0.5-1.0 units/kg/day without adding prandial coverage 1, 4
  • Avoid injecting into areas of lipodystrophy, as this can cause hyperglycemia 3

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Insulin Glargine Starting Dose Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Maximum Daily Dose of Lantus (Insulin Glargine)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can a patient with diabetes divide their Lantus (insulin glargine) dose and take it twice a day?
What is the recommended frequency for titrating up Lantus (insulin glargine) in patients with diabetes, considering factors such as age, renal function, and comorbidities?
What adjustments should be made to the treatment plan for a patient with uncontrolled hyperglycemia on Lantus (insulin glargine) 12 units?
What is the recommended increase in Lantus (insulin glargine) dose for a patient with hyperglycemia, who previously used an insulin pump with basal needs ranging from 19-29 units, and is now taking 10 units of Lantus with a fasting blood glucose level of 220 and overnight blood glucose level of 179?
How to titrate twice daily (bid) Lantus (insulin glargine) in a patient with diabetes?
What is the approach to understanding and treating lymphoma in an adult patient with no prior medical history?
What are the treatment options for a patient with global aphasia and significant lack of comprehension?
What is the best management approach for an elderly patient with newly diagnosed hyperthyroidism, tachycardia, and mild liver enzyme elevations, who is currently taking lovastatin for hypercholesterolemia?
What is a normal glucose level after eating liquid food in a patient with diabetes or prediabetes?
How to diagnose pyloric stenosis in an infant presenting with symptoms such as projectile vomiting?
What is the best treatment approach for an adult male with hearing aids and recurrent otitis externa?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.